Related Experiment Video

Updated: Apr 1, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K

Authors' Response to "Comment on 'Improving Care for Amyotrophic Lateral Sclerosis with Artificial Intelligence and

Marc Garbey1, Quentin Lesport2, Gülşen Öztosun3

  • 1Department of Surgery, George Washington University School of Medicine & Health Sciences, Washington, DC, USA; Care Constitution Corp, Houston, TX, USA; Laboratoire des Sciences de l'Ingénieur pour l'Environnement (LaSIE) UMR-CNRS 7356 University of La Rochelle, France; Department of Neurology & Rehabilitation Medicine, George Washington University School of Medicine & Health Sciences, Washington, DC, USA.

Journal of the Neurological Sciences
|March 30, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Affective computingAmyotrophic lateral sclerosisArtificial intelligenceClinical trialsNatural language processingPatient-centered careSignal analysis

More Related Videos

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

36.2K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K